Jennifer Flemming
Jennifer Flemming
Associate Professor
Division of Gastroenterology
Department of Medicine
School of Medicine
jennifer.flemming2@kingstonhsc.ca
Homepage
0000-0002-9911-0925
Google Scholar Profile
ProfessorEveryone

Research Description

Dr Jennifer Flemming joined the Faculty of Medicine at Queen’s University in 2014 as a member of the Division of Gastroenterology. Dr. Flemming is also the ICES-Queen's Site Director since 2022. She completed medical school at Dalhousie University (2006) and completed Internal Medicine (2009) and Gastroenterology training (2011) at Queen’s University. She then spent two years at the University of California San Francisco completing sub-specialty training in Hepatology and Liver Transplantation as well as obtaining her Master’s Degree (MAS) in Advanced Clinical Research. Dr. Flemming is a Southeastern Ontario Academic Medical Association (SEAMO) Clinician Scientist with 70% of her time protected for research activity. She is a member of the Cancer Care and Epidemiology (CCE) group at the Cancer Research Institute at Queen’s University with a cross appointment to the Department of Public Health Sciences. Her health services research program focuses on the epidemiology and natural history of cirrhosis and primary liver cancers.

Dr. Flemming is the first in Canada studying the links between cirrhosis and biliary tract cancer (a rare subset of liver cancer) from both a clinical and population perspective. One of her studies, conducted in the division of Cancer Care and Epidemiology (CCE) at the Queen’s Cancer Research Institute, involved extracting information from pathology reports in patients with biliary tract cancer and looking at the natural history, treatment outcomes, and mortality trends in this population. She also looked at the burden of chronic liver disease and cirrhosis in Ontario and the association between cirrhosis and biliary tract cancers. This work enabled quantifying the burden of biliary tract cancer across the Ontario population, and then identify disease trends, risk factors, and outcomes. The results of this study have been used to justify the development of a chronic disease management strategy for Canadians with liver disease.

Dr. Jennifer Flemming has interests in Cirrhosis, Biliary and Liver Cancer, Hepatitis C, Liver Transplant, Non-alcoholic Fatty Liver Disease, Models of Health Care Delivery, Gastrointestinal Cancer, Primary Liver Cancers, Digestive Disease, Kidney, and Endocrinology, and Health Systems, Public Health, and Quality Improvement research.  

Selected Degrees

Canadian Women in Medicine Leadership Development Series (January 2022) –
Advanced Clinical Research (June 2013) – University of California, San Francisco
MD - Medicine (May 2006) – Dalhousie University
Science (May 2000) – Saint Mary's University

Biography

Dr. Flemming is an Associate Professor of Medicine and Public Health Sciences at Queen’s University with clinical training in gastroenterology, hepatology, and liver transplantation. She is also the ICES-Queen's Site Director since 2022. After completing her Internal Medicine and Gastroenterology training at Queen’s University, she completed two years of advanced hepatology and a Master’s in Clinical Research at the University of California San Francisco. She is a clinician scientist who leads a research program which leverages Ontario administrative data housed at ICES to evaluate the epidemiology and outcomes of patients with cirrhosis. Her research has been supported by the American Association for the Study of Liver Disease (AASLD), the American Gastroenterological Association (AGA) and the Canadian Donation and Transplantation Research Program. She also serves as the Chair for the Guidelines Committee of the Canadian Association for the Study of Liver Disease (CASL), is a member of the CASL Equity, Diversity and Inclusion committee in addition to being a member of the AASLD Women’s Initiatives Committee.

Research Places

(July 1, 2022 - )

ICES-Queen's

Division of Gastroenterology 

Queen's University